DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
INSULIN PEGLISPRO
3
Protein
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Insulin receptor agonist
INSULIN PEGLISPRO
×
Maximum Phase:
3
First Approval:
None
UNII:
6Y83I5F10I
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FASINUMAB
3
Antibody
Investigational
Unknown
Unknown
Abdominal Pain; Back Pain; Low Back Pain; Osteoarthritis; Sciatica; Osteoarthritis, Hip; Osteoarthritis, Knee
Beta-nerve growth factor inhibitor
FASINUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
11T51Q3082
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RADIUM BROMATUM
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RADIUM BROMATUM
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAUROLITHOCHOLIC ACID
3
Small molecule
Investigational
Unknown
Unknown
Liver Cirrhosis; Asthma; Multiple Sclerosis; Diabetes Mellitus, Type 1; Amyotrophic Lateral Sclerosis; Liver Cirrhosis, Biliary
Unknown
TAUROLITHOCHOLIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H45NO5S
Molecular Weight:
483.72
AlogP:
4.43
PSA:
103.7
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BENEGRASTIM
3
Protein
Investigational
Unknown
Unknown
Neutropenia; Breast Neoplasms
Unknown
BENEGRASTIM
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMAZEPAM
3
Small molecule
Investigational
Unknown
Unknown
Dementia; Depressive Disorder; Schizophrenia; Anxiety
GABA receptor alpha-2 subunit positive allosteric modulator
BROMAZEPAM
×
Maximum Phase:
3
First Approval:
None
UNII:
X015L14V0O
Molecule Type:
Small molecule
Molecular Formula:
C14H10BrN3O
Molecular Weight:
316.16
AlogP:
2.63
PSA:
54.35
HBD:
1.0
HBA:
#RotB:
1.0
Source:
VANIPREVIR
3
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Infections; Hepatitis C, Chronic
Hepatitis C virus serine protease, NS3/NS4A inhibitor
VANIPREVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
CV3X74AO1H
Molecule Type:
Small molecule
Molecular Formula:
C38H53N5O9S
Molecular Weight:
755.93
AlogP:
3.67
PSA:
180.52
HBD:
3.0
HBA:
#RotB:
6.0
Source:
EDRECOLOMAB
3
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
Epithelial cell adhesion molecule cross-linking agent
EDRECOLOMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
0KYI9U9FSJ
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELAFIBRANOR
3
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Diabetes Mellitus, Type 2; Non-alcoholic Fatty Liver Disease; Liver Cirrhosis, Biliary
Peroxisome proliferator-activated receptor alpha agonist
ELAFIBRANOR
×
Maximum Phase:
3
First Approval:
None
UNII:
2J3H5C81A5
Molecule Type:
Small molecule
Molecular Formula:
C22H24O4S
Molecular Weight:
384.5
AlogP:
5.16
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TAVILERMIDE
3
Protein
Investigational
Unknown
Unknown
Dry Eye Syndromes
Unknown
TAVILERMIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
NMG938VJ6T
Molecule Type:
Protein
Molecular Formula:
C24H32N6O11
Molecular Weight:
580.55
AlogP:
-1.36
PSA:
269.39
HBD:
7.0
HBA:
#RotB:
11.0
Source:
EDIFOLIGIDE SODIUM
3
Oligonucleotide
Investigational
Unknown
Unknown
Coronary Disease
E2F inhibitor
EDIFOLIGIDE SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
8TW510F64S
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXOMEMAZINE
3
Small molecule
Investigational
Unknown
Unknown
Cough; Hypersensitivity
Unknown
OXOMEMAZINE
×
Maximum Phase:
3
First Approval:
None
UNII:
Q824SGH3RN
Molecule Type:
Small molecule
Molecular Formula:
C18H22N2O2S
Molecular Weight:
330.45
AlogP:
3.17
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TIAPRIDE
3
Small molecule
Investigational
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Psychotic Disorders; Schizophrenia; Tourette Syndrome
Dopamine D2 receptor antagonist
TIAPRIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
LAH70H9JPH
Molecule Type:
Small molecule
Molecular Formula:
C15H24N2O4S
Molecular Weight:
328.43
AlogP:
1.17
PSA:
75.71
HBD:
1.0
HBA:
#RotB:
8.0
Source:
POLYGLACTIN 910
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
POLYGLACTIN 910
×
Maximum Phase:
3
First Approval:
None
UNII:
51L8Z461QZ
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IDRABIOTAPARINUX SODIUM
3
Oligosaccharide
Investigational
Unknown
Unknown
Atrial Fibrillation; Thrombosis; Venous Thrombosis
Unknown
IDRABIOTAPARINUX SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
K2T918I23K
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PI-88
3
Oligosaccharide
Investigational
Unknown
Unknown
Unknown
Unknown
PI-88
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBIMAZOLE
3
Small molecule
Investigational
Unknown
Unknown
Thyrotoxicosis; Thyroid Diseases
Thyroid peroxidase inhibitor
CARBIMAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
8KQ660G60G
Molecule Type:
Small molecule
Molecular Formula:
C7H10N2O2S
Molecular Weight:
186.24
AlogP:
1.56
PSA:
36.16
HBD:
0.0
HBA:
#RotB:
1.0
Source:
FURAPREVIR
3
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic; Hepatitis C
Hepatitis C virus serine protease, NS3/NS4A inhibitor
FURAPREVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
0UMM44REU9
Molecule Type:
Small molecule
Molecular Formula:
C47H56N6O10S
Molecular Weight:
897.06
AlogP:
6.61
PSA:
208.36
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MELPHALAN FLUFENAMIDE HYDROCHLORIDE
3
Small molecule
Investigational
Unknown
Unknown
Amyloidosis, Familial; Kidney Diseases; Multiple Myeloma
DNA cross-linking agent
MELPHALAN FLUFENAMIDE HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
3412470A0V
Molecule Type:
Small molecule
Molecular Formula:
C24H31Cl3FN3O3
Molecular Weight:
534.89
AlogP:
3.27
PSA:
84.66
HBD:
2.0
HBA:
#RotB:
13.0
Source:
ROVATIRELIN
3
Small molecule
Investigational
Unknown
Unknown
Cerebellar Ataxia
Unknown
ROVATIRELIN
×
Maximum Phase:
3
First Approval:
None
UNII:
9DL0X410PY
Molecule Type:
Small molecule
Molecular Formula:
C16H22N4O4S
Molecular Weight:
366.44
AlogP:
0.68
PSA:
100.63
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CIMETROPIUM BROMIDE
3
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases
Unknown
CIMETROPIUM BROMIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
0C7M5WE60Q
Molecule Type:
Small molecule
Molecular Formula:
C21H28BrNO4
Molecular Weight:
438.36
AlogP:
1.84
PSA:
59.06
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ALZ-801
3
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
ALZ-801
×
Maximum Phase:
3
First Approval:
None
UNII:
GHG2B47067
Molecule Type:
Small molecule
Molecular Formula:
C8H18N2O4S
Molecular Weight:
238.31
AlogP:
-0.64
PSA:
109.49
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BEAM
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BEAM
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TANNIC ACID
3
Unknown
Investigational
Unknown
Unknown
Gastroenteritis
Unknown
TANNIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
28F9E0DJY6
Molecule Type:
Unknown
Molecular Formula:
C76H52O46
Molecular Weight:
1701.21
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ENISAMIUM IODIDE
3
Small molecule
Investigational
Unknown
Unknown
Influenza, Human; Severe Acute Respiratory Syndrome; Virus Diseases
Unknown
ENISAMIUM IODIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
G22FG6Q00B
Molecule Type:
Small molecule
Molecular Formula:
C14H15IN2O
Molecular Weight:
354.19
AlogP:
1.44
PSA:
32.98
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CAR
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CAR
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIANICLINE
3
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder
Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
DIANICLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
Y0SNM34C6O
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2O
Molecular Weight:
216.28
AlogP:
1.48
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
0.0
Source:
OZARELIX
3
Protein
Investigational
Unknown
Unknown
Prostatic Hyperplasia; Prostatic Neoplasms, Castration-Resistant
Gonadotropin-releasing hormone receptor antagonist
OZARELIX
×
Maximum Phase:
3
First Approval:
None
UNII:
Q1IF8M2YL3
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAMOCAFTOR
3
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
BAMOCAFTOR
×
Maximum Phase:
3
First Approval:
None
UNII:
8C7XEW3K7S
Molecule Type:
Small molecule
Molecular Formula:
C28H32F3N5O4S
Molecular Weight:
591.66
AlogP:
5.12
PSA:
106.42
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ALMONERTINIB
3
Unknown
Investigational
Unknown
Unknown
Adenocarcinoma of Lung; Carcinoma, Squamous Cell; Lung Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
ALMONERTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HIBERIX
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HIBERIX
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DENUFOSOL
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DENUFOSOL
×
Maximum Phase:
3
First Approval:
None
UNII:
5PC250KSSH
Molecule Type:
Small molecule
Molecular Formula:
C18H27N5O21P4
Molecular Weight:
773.32
AlogP:
-2.87
PSA:
390.27
HBD:
9.0
HBA:
#RotB:
14.0
Source:
CINITAPRIDE
3
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases; Dyspepsia
Unknown
CINITAPRIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
R8I97I2L24
Molecule Type:
Small molecule
Molecular Formula:
C21H30N4O4
Molecular Weight:
402.5
AlogP:
3.13
PSA:
110.73
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OMEGA-3-PENTAENOIC ACIDS
3
Small molecule
Investigational
Unknown
Unknown
Hypertriglyceridemia
Unknown
OMEGA-3-PENTAENOIC ACIDS
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C63H96O6
Molecular Weight:
949.45
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
COBITOLIMOD
3
Unknown
Investigational
Unknown
Unknown
Colitis, Ulcerative
Toll-like receptor 9 agonist
COBITOLIMOD
×
Maximum Phase:
3
First Approval:
None
UNII:
328101264R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
237
238
239
240
241
242
243
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA